Latest Articles
Genetic risk may rival obesity as a key driver of endometrial cancer - Medical Xpress
Genetic risk may rival obesity as a key driver of endometrial cancer Medical Xpress
Published: Feb. 12, 2026, 8:16 p.m.
How Should Inoperable Endometrial Cancer be Treated? - CancerNetwork
How Should Inoperable Endometrial Cancer be Treated? CancerNetwork
Published: Feb. 12, 2026, 4:05 p.m.
Totus Medicines to Present Updated Phase 1 Clinical Data for TOS-358 at ESMO Targeted Anticancer Therapies Congress 2026 - The Manila Times
Totus Medicines to Present Updated Phase 1 Clinical Data for TOS-358 at ESMO Targeted Anticancer Therapies Congress 2026 The Manila Times
Published: Feb. 12, 2026, 1:07 p.m.
More Good News for GLP-1 Agonists and Cancer Risk - MedPage Today
More Good News for GLP-1 Agonists and Cancer Risk MedPage Today
Published: Feb. 11, 2026, 10:33 p.m.
The Scan by 2 Minute Medicine®: Daily caffeine intake linked to lower dementia risk, AAP sues over federal vaccine schedule overhaul, Catherine O’Hara passes away after short illness, and GLP-1 receptor agonists reduce endometrial cancer risk - 2 Minute Medicine
The Scan by 2 Minute Medicine®: Daily caffeine intake linked to lower dementia risk, AAP sues over federal vaccine schedule overhaul, Catherine O’Hara passes away after short illness, and GLP-1 …
Published: Feb. 11, 2026, 6:31 p.m.
The Intricacy and Importance of Treating Inoperable Endometrial Cancer - CancerNetwork
The Intricacy and Importance of Treating Inoperable Endometrial Cancer CancerNetwork
Published: Feb. 11, 2026, 6:02 p.m.
Research sheds light on key drivers of endometrial cancer - The National Tribune
Research sheds light on key drivers of endometrial cancer The National Tribune
Published: Feb. 11, 2026, 2:10 p.m.
Endometrial Cancer Treatment Market Is Going to Boom |• Merck & Co. • Bristol-Myers Squibb - openPR.com
Endometrial Cancer Treatment Market Is Going to Boom |• Merck & Co. • Bristol-Myers Squibb openPR.com
Published: Feb. 11, 2026, 12:24 p.m.
GLP-1s Plus Progestins Tied to Lower Endometrial Cancer Risk - Medscape
GLP-1s Plus Progestins Tied to Lower Endometrial Cancer Risk Medscape
Published: Feb. 11, 2026, 8:49 a.m.
AstraZeneca Pharma India Secures CDSCO Nod for Expanded Use of Durvalumab in Cancer Treatment - NewsGram
AstraZeneca Pharma India Secures CDSCO Nod for Expanded Use of Durvalumab in Cancer Treatment NewsGram
Published: Feb. 11, 2026, 3:33 a.m.
Link copied to clipboard!